Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment

Kawasaki disease (KD) is anacute febrile coronary vasculitis disease in children. In general, this disease can be treated with a single dose of 2 g/kg intravenous immunoglobulin (IVIG). However, the best timing for administering steroid treatment in acute-stage KD is still under debate. In this stud...

Full description

Bibliographic Details
Main Authors: Ying-Hsien Huang, Kuang-Den Chen, Mao-Hung Lo, Xin-Yuan Cai, Ho-Chang Kuo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fped.2019.00007/full
_version_ 1811203792489676800
author Ying-Hsien Huang
Ying-Hsien Huang
Kuang-Den Chen
Kuang-Den Chen
Mao-Hung Lo
Mao-Hung Lo
Xin-Yuan Cai
Xin-Yuan Cai
Ho-Chang Kuo
Ho-Chang Kuo
author_facet Ying-Hsien Huang
Ying-Hsien Huang
Kuang-Den Chen
Kuang-Den Chen
Mao-Hung Lo
Mao-Hung Lo
Xin-Yuan Cai
Xin-Yuan Cai
Ho-Chang Kuo
Ho-Chang Kuo
author_sort Ying-Hsien Huang
collection DOAJ
description Kawasaki disease (KD) is anacute febrile coronary vasculitis disease in children. In general, this disease can be treated with a single dose of 2 g/kg intravenous immunoglobulin (IVIG). However, the best timing for administering steroid treatment in acute-stage KD is still under debate. In this study, we recruited 174 participants to survey the transcript levels of steroid hormone receptors in KD patients. The chip studies consisted of 18 KD patients that were analyzed before IVIG treatment and at least 3 weeks after IVIG administration, as well as 36 control subjects, using GeneChip® HTA 2.0. Another cohort consisting of 120 subjects was analyzed to validate qRT-PCR. Our microarray study demonstrated significant downregulated expressions of the mRNA levels of NR1A2, RORA, NR4A1-3, THRA, and PPARD in KD patients in comparision to the controls. However, these genes increased considerably in KD patients after IVIG administration. After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. Our study is the first to report the potential effective utilization of steroid treatment in KD. Prior to IVIG treatment, decreased steroid receptors allowed for the reduced treatment role of steroids. However, after IVIG treatment, increased steroid receptors indicate that steroids are effective as a supplementary treatment for KD.
first_indexed 2024-04-12T03:02:15Z
format Article
id doaj.art-d6f88bbc9f8c4a56ad1a4ff5f60a5d85
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-12T03:02:15Z
publishDate 2019-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-d6f88bbc9f8c4a56ad1a4ff5f60a5d852022-12-22T03:50:38ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602019-02-01710.3389/fped.2019.00007435642Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG TreatmentYing-Hsien Huang0Ying-Hsien Huang1Kuang-Den Chen2Kuang-Den Chen3Mao-Hung Lo4Mao-Hung Lo5Xin-Yuan Cai6Xin-Yuan Cai7Ho-Chang Kuo8Ho-Chang Kuo9Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanKawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanKawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanDepartment of Surgery, Liver Transplantation Center, Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanKawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanDepartment of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanKawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanDepartment of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanKawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanKawasaki disease (KD) is anacute febrile coronary vasculitis disease in children. In general, this disease can be treated with a single dose of 2 g/kg intravenous immunoglobulin (IVIG). However, the best timing for administering steroid treatment in acute-stage KD is still under debate. In this study, we recruited 174 participants to survey the transcript levels of steroid hormone receptors in KD patients. The chip studies consisted of 18 KD patients that were analyzed before IVIG treatment and at least 3 weeks after IVIG administration, as well as 36 control subjects, using GeneChip® HTA 2.0. Another cohort consisting of 120 subjects was analyzed to validate qRT-PCR. Our microarray study demonstrated significant downregulated expressions of the mRNA levels of NR1A2, RORA, NR4A1-3, THRA, and PPARD in KD patients in comparision to the controls. However, these genes increased considerably in KD patients after IVIG administration. After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. Our study is the first to report the potential effective utilization of steroid treatment in KD. Prior to IVIG treatment, decreased steroid receptors allowed for the reduced treatment role of steroids. However, after IVIG treatment, increased steroid receptors indicate that steroids are effective as a supplementary treatment for KD.https://www.frontiersin.org/article/10.3389/fped.2019.00007/fullKawasaki disease (KD)steroid receptorNr4a2immunologyIVIG = intravenous immunoglobulin
spellingShingle Ying-Hsien Huang
Ying-Hsien Huang
Kuang-Den Chen
Kuang-Den Chen
Mao-Hung Lo
Mao-Hung Lo
Xin-Yuan Cai
Xin-Yuan Cai
Ho-Chang Kuo
Ho-Chang Kuo
Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
Frontiers in Pediatrics
Kawasaki disease (KD)
steroid receptor
Nr4a2
immunology
IVIG = intravenous immunoglobulin
title Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
title_full Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
title_fullStr Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
title_full_unstemmed Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
title_short Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
title_sort decreased steroid hormone receptor nr4a2 expression in kawasaki disease before ivig treatment
topic Kawasaki disease (KD)
steroid receptor
Nr4a2
immunology
IVIG = intravenous immunoglobulin
url https://www.frontiersin.org/article/10.3389/fped.2019.00007/full
work_keys_str_mv AT yinghsienhuang decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT yinghsienhuang decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT kuangdenchen decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT kuangdenchen decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT maohunglo decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT maohunglo decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT xinyuancai decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT xinyuancai decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT hochangkuo decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment
AT hochangkuo decreasedsteroidhormonereceptornr4a2expressioninkawasakidiseasebeforeivigtreatment